
View larger version (79K):
[in a new window]
|
Fig. 5. (A-I,A'-I') Suppression of Cs-Twist-like1 using
specific morpholinos, showing the effects on: larval morphology (A,A');
the expression of the epidermis-specific gene Cs-Epi1 (B,B'),
the pan-neural marker gene Cs-ETR (C,C'), the
notochord-specific gene Csfibrn (D,D'), and the muscle-specific
actin gene Cs-MA1 (E,E',H,H'); the endoderm-specific
histochemical activity of alkaline phosphatase (F,F',I,I'); and
the mesenchyme-specific gene Cs-Mech1 (G,G'). (A-I) Control
embryos. (A'-I') Embryos developed from eggs injected with the
Twist-like1-morpholino. (H,H',I,I') Embryos arrested at
the 110-cell stage. Arrows in E' and H' indicate the appearance of
extra cells with Cs-MA1 expression. Arrows in I' indicate the
occurrence of extra cells with histochemically detected activity of alkaline
phosphatase. Arrowheads in I and I' indicate pigmented cells that are
not alkaline-phosphatase positive. (J,K) Effect of overexpression of
Cs-Twist-like1 mRNA as assessed by expression of Cs-Mech1
(J) and Cs-Twist-like2 (K). (L,M) Co-injection of the
Cs-FGF9/16/20 morpholino and Cs-Twist-like1 mRNA resulted in
the recovery of Cs-Mech1 (L) and Cs-Twist-like2 (M)
expression. The insets in L and M are control embryos injected with the
Cs-FGF9/16/20 morpholino and examined for Cs-Mech1 (L) and
Cs-Twist-like2 (M) expression.
|